Cosmetics

Bryan Johnson Considers Divesting Anti-Aging Venture to Propagate New Longevity Philosophy

In a significant shift, Bryan Johnson, a prominent figure in the longevity movement, is considering the cessation of operations or sale of his anti-aging enterprise, Blueprint. This strategic reevaluation stems from his growing commitment to a personal philosophy he terms “Don't Die,” which he views as central to his mission. The decision underscores a divergence between his entrepreneurial pursuits and his evolving role as an evangelist for extended human lifespans, suggesting that the commercial aspects of his venture may no longer align with his overarching vision for promoting radical longevity.

Bryan Johnson, aged 47, has garnered considerable attention for his rigorous and costly anti-aging practices, which reportedly involve an annual expenditure of US$2 million. His unconventional approaches have included widely discussed, and at times controversial, procedures such as blood plasma transfusions. These personal commitments have formed the foundation of his public persona as a longevity advocate. However, in recent discussions with Wired magazine, Johnson indicated that the operational demands of Blueprint are proving counterproductive to his core message. He conveyed that running the startup diminishes his authority and authenticity as a proponent of long-term health and vitality.

Blueprint, Johnson's company, offers a range of products aimed at enhancing longevity and well-being. These include a \"longevity mix\" priced at US$55 and a \"Super Shrooms\" coffee alternative retailed at US$42. Despite these offerings and Johnson's assertions regarding the company's financial health, reports suggest that Blueprint has encountered difficulties in achieving a break-even point. This financial context, coupled with Johnson's evolving personal beliefs, has spurred his consideration of exiting the commercial venture. His declared intention to pivot from merely selling health-related products to actively promoting a broader lifestyle movement highlights a fundamental tension between the commercial landscape of wellness entrepreneurship and the articulation of a deeply held personal philosophy.

This potential divestiture signifies a noteworthy transformation in Johnson's professional trajectory and public engagement. It illustrates a transition from a product-centric business model to a more philosophy-driven platform, where the propagation of his "Don't Die" religion takes precedence over the direct sale of anti-aging commodities. Such a move would allow Johnson to focus on his ideological advocacy without the perceived conflicts of interest inherent in running a commercial enterprise. The underlying dynamic here is a shift from profit-driven product distribution to the widespread dissemination of a lifestyle ethos, reshaping his influence within the wellness and longevity communities.

Related Articles

Unilever's Robust First-Half Growth Driven by Beauty and Personal Care Divisions
Cosmetics

Unilever's Robust First-Half Growth Driven by Beauty and Personal Care Divisions

Unilever reports a strong 3.4% underlying sales growth in the first half of 2025, with impressive performance in its Beauty & Wellbeing and Personal Care segments. This growth is fueled by balanced volume and price increases, particularly in developed markets and improving trends in emerging economies like India. The company remains confident in its full-year projections and continues to focus on strategic investments and the demerger of its Ice Cream business.

Aug 01, 2025
AESTURA Skincare Brand to Debut Exclusively at Sephora Australia
Cosmetics

AESTURA Skincare Brand to Debut Exclusively at Sephora Australia

Korean derma-cosmetic brand AESTURA, renowned for its barrier-strengthening ATOBARRIER365 Cream, is set to launch exclusively at Sephora Australia, both in stores and online, starting August 26, 2025. This strategic move aims to cater to the increasing Australian consumer demand for scientifically-backed and dermatologist-recommended K-beauty solutions, offering effective formulas to combat dryness, irritation, and skin barrier damage prevalent in the country's climate.

Aug 01, 2025
Nestlé Re-evaluates Wellness Portfolio, Eyes Divestment of Underperforming Vitamin Brands
Cosmetics

Nestlé Re-evaluates Wellness Portfolio, Eyes Divestment of Underperforming Vitamin Brands

Nestlé is currently undertaking a strategic review of its extensive vitamins, minerals, and supplements (VMS) business, with a particular focus on brands like Nature's Bounty, Osteo Bi-Flex, and Puritan's Pride. This evaluation comes as the company seeks to divest underperforming assets and pivot towards more premium, science-backed offerings such as Garden of Life and Solgar. The 2021 acquisition of Bountiful, valued at US$5.75 billion, has faced challenges with decelerating sales growth and a decline in net profit, leading to a 6% drop in shares. This move aligns with a broader trend in the fast-moving consumer goods (FMCG) sector, where companies are optimizing their portfolios to prioritize profitability and adapt to evolving consumer demands for value.

Aug 01, 2025